Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H22FN5O7 |
Molecular Weight | 487.4378 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12[C@H](C)O[C@H](C)CN1C3=C(CC24C(=O)NC(=O)NC4=O)C=C5C(=NOC5=C3F)N6[C@@H](C)COC6=O
InChI
InChIKey=ZSWMIFNWDQEXDT-ZESJGQACSA-N
InChI=1S/C22H22FN5O7/c1-8-7-33-21(32)28(8)17-12-4-11-5-22(18(29)24-20(31)25-19(22)30)16-10(3)34-9(2)6-27(16)14(11)13(23)15(12)35-26-17/h4,8-10,16H,5-7H2,1-3H3,(H2,24,25,29,30,31)/t8-,9+,10-,16+/m0/s1
Zoliflodacin (also known as AZD0914 or ETX0914) is a spiropyrimidinetrione with activity against bacterial type II topoisomerases that inhibits DNA biosynthesis and results in accumulation of double-strand cleavages in bacteria. This drug is being a DNA gyrase inhibitor, targeting Neisseria gonorrhoeae and is currently in phase II clinical trial in adults to treat uncomplicated urogenital gonorrhea.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae. | 2014 Dec |
|
High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea. | 2014 Sep |
|
Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea. | 2018 Nov 8 |
|
Single-Dose Pharmacokinetics, Excretion, and Metabolism of Zoliflodacin, a Novel Spiropyrimidinetrione Antibiotic, in Healthy Volunteers. | 2019 Jan |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02257918
AZD0914 (ZOLIFLODACIN) is an antimicrobial amorphous nonsterile powder. Group 1 receive 2000 mg; Group 2 receive 3000 mg.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C258
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300000009721
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
DTXSID101028418
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
1620458-09-4
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
DB12817
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
FWL2263R77
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
76685216
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
10285
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
Zoliflodacin
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL3544978
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
CD-63
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
C152962
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY |
ACTIVE MOIETY